A. Rothner | Semantic Scholar

A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents

P. Winner, A. Rothner, M. Peykamian
Medicine
Pediatrics
1 November 2000

Sumatriptan NS is effective and well-tolerated for the treatment of acute migraine in adolescents, with the 20-mg dose providing the best overall efficacy and tolerability profiles.

View on Publisher

Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double‐Blind, Placebo‐Controlled, Acute Study

P. Winner, A. Rothner, J. Wooten, C. Webster, M. Ames
Medicine, Psychology
Headache
1 February 2006

The efficacy and tolerability of sumatriptan nasal spray (NS) (5, 20 mg) versus placebo in the acute treatment of migraine in adolescent subjects is compared.

View on Wiley

“Benign” Imaging Abnormalities in Children and Adolescents With Headache

T. Schwedt, Yifan Guo, A. Rothner
Medicine, Psychology
Headache
1 March 2006

The frequency of “benign” abnormalities on brain imaging in children with headache is compared with the frequency of imaging findings that dictate a change in patient management, to determine the association of benign findings with headache.

View on Wiley

Zolmitriptan Oral Tablet in Migraine Treatment: High Placebo Responses in Adolescents

A. Rothner, W. Wasiewski, P. Winner, D. Lewis, J. Stankowski
Medicine, Psychology
Headache
1 January 2006

This randomized, double‐blind, placebo‐controlled study evaluated the efficacy and tolerability of the zolmitriptan conventional tablet at three different doses for the treatment of a single migraine attack in adolescents.

View on Wiley

Use of the ICHD‐II Criteria in the Diagnosis of Pediatric Migraine

A. Hershey, P. Winner, S. Powers
Medicine, Psychology
Headache
1 November 2005

The new International Classification of Headache Disorders‐2nd edition (ICHD‐II) criteria in the diagnosis of childhood migraine is evaluated and a specific criteria for the diagnosis is proposed.

View on Wiley

One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study.

A. Rothner, P. Winner, M. Peykamian
Medicine
Clinical therapeutics
1 December 2000

View on PubMed

Demographic and Migraine Characteristics of Adolescents With Migraine: Glaxo Wellcome Clinical Trials' Database

P. Winner, A. Rothner, D. G. Putnam, M. Asgharnejad
Medicine, Psychology
Headache
1 May 2003

The demographics and migraine characteristics of patients in the Glaxo Wellcome adolescent clinical trials' database are described to describe the demographics and headaches of patients.

View on Wiley

Randomized Trial of Sumatriptan and Naproxen Sodium Combination in Adolescent Migraine

Frederick J. Derosier, D. Lewis, M. Runken
Medicine, Psychology
Pediatrics
1 June 2012

All doses of suma/nap were well tolerated, providing similarly effective acute treatment of adolescent migraine pain and associated symptoms, as compared with placebo.

View on Publisher

2-21-15 Efficacy and safety of naratriptan tablets in adolescent migraine

A. Rothner, K. Edwards, L. Kerr, S. Debussey, M. Asgharnejad
Psychology
Journal of the Neurological Sciences
1 September 1997

View on Elsevier

Migraine Variants or Episodic Syndromes That May Be Associated With Migraine and Other Unusual Pediatric Headache Syndromes

A. Rothner, S. Parikh
Psychology, Medicine
Headache
1 January 2016

An overview of the clinical course for children and adolescents with migraine variants (M.V.) or the episodic syndromes that may be associated with migraine using the International Classification of Headache Disorders, 3rd Edition Beta version [ICHD‐3] International Headache Society criteria for the diagnosis of each disorder is provided.

View on Wiley